Mary Hoelscher

Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice

Mary Hoelscher, Sanjay Garg, Dinesh S. Bangari et al. · The Lancet · 2006 · 187 citations · Full text

Vaccination, Vaccine Development, Vaccine Target +8

A Broadly Protective Vaccine against Globally Dispersed Clade 1 and Clade 2 H5N1 Influenza Viruses

Mary Hoelscher, Neetu Singh, Sanjay Garg et al. · The Journal of Infectious Diseases · 2008 · 61 citations · Full text

Clade 2, Immunology, Molecular Biology +16

Needle-Free Skin Patch Delivery of a Vaccine for a Potentially Pandemic Influenza Virus Provides Protection against Lethal Challenge in Mice

Sanjay Garg, Mary Hoelscher, Jessica A. Belser et al. · Clinical and Vaccine Immunology · 2007 · 43 citations · Full text

Vaccination, Lethal Challenge, Cross-protection +14

New Pre-pandemic Influenza Vaccines: An Egg- and Adjuvant-independent Human Adenoviral Vector Strategy Induces Long-lasting Protective Immune Responses in Mice

Mary Hoelscher, Lakshmi Jayashankar, S. K. Garg et al. · Clinical Pharmacology & Therapeutics · 2007 · 41 citations · Full text

Vaccination, Cross-protection, Southeast Asia +13

5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication

Priya Ranjan, Lakshmi Jayashankar, Varough Deyde et al. · Virology Journal · 2010 · 32 citations · Full text